Document is current
Any future updates will be listed below
-
Authors
Rasmussen, Martin Bo
Holgersen, Kristine
Pankratova, Stanislava
Bæk, Ole
Burrin, Douglas G.
Thymann, Thomas
Sangild, Per Torp
-
Funding
Funding for this research was provided by:
Takeda Pharmaceuticals International
- License Information
-
More Information
Article History
Received: 31 May 2023
Revised: 31 October 2023
Accepted: 18 November 2023
First Online: 12 December 2023
Competing interest
: The University of Copenhagen, represented by authors K.H., S.P., O.B., T.T. and P.T.S. and the company Oak Hill Bio have filed a patent application directed to the use of rhIGF-1 for preterm infants. The company reviewed the manuscript for comments but did not have final editorial rights over the text.
